Health Network Laboratories Appoints Xinjing Wang, PhD as Director of Clinical Genomics
July 29, 2019
Health Network Laboratories (HNL), a leader in high quality, innovative laboratory medicine services, announced the appointment of Xinjing Wang, PhD as Director of Clinical Genomics. In this role, Dr. Wang will work directly with Senior Leadership, Business Development, and Laboratory Operations staff and act as the medical and technical liaison between the clinical genomics services offered by HNL and its clients.
Dr. Wang is responsible for the overall direction, operation, strategic planning, new test development and coordination and support of all clinical genomics services including NGS sequencing, molecular diagnostics, and cytogenetics.
“We are extremely pleased to welcome Dr. Wang to the HNL team and look forward to gaining the benefit of his expertise in this field,” said Matt Sorrentino, acting President, and CEO of HNL. “Dr. Wang’s extensive experience in Clinical Molecular Genetics make him a valuable addition to our leadership team as we continue to expand the company and its services to the community.”
Dr. Wang currently serves as the Associate Director of Genetics Laboratory, Department of Pediatrics at The University of Oklahoma Health Sciences Center and is certified by the American Board of Medical Genetics and Genomics (ABMGG) in Clinical Molecular Genetics and Clinical Cytogenetics.
“I’m thrilled to be a part of HNL and work with such an extraordinary team who share my commitment to this industry,” added Dr. Wang. “My focus is to accomplish the organizational goals while evaluating new and emerging technology and develop superior tests that will add value and improve services in a clinically meaningful and cost-effective way to healthcare providers and patients.”
Prior to HNL, Dr. Wang was the Director at the National Eye Institute/NIH, an NEI DNA Diagnostic Laboratory in Bethesda, Maryland. He also served as the Medical Director of Molecular Diagnostics Laboratory, Department of Laboratory Medicine and Pathology at the University of Minnesota and held multiple positions as Director, Assistant Laboratory Director and R&D Director at Johns Hopkins University School of Medicine, McKusick-Nathans Institute of Genetic Medicine in Baltimore, Maryland.
Dr. Wang received his Bachelor of Medicine from Beijing University and earned his PhD at The SUNY, Buffalo. Dr. Wang completed his Clinical Fellowships in Molecular Genetics and Clinical Cytogenetics at Johns Hopkins University, McKusick-Nathans Institute of Genetic Medicine.
Media Contact: Leanne Aquino